Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Bio-Techne Stock: Analyst Estimates & Ratings

Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets. Valued at $8.4 billion by market cap, the company specializes in proteins, cytokines, growth factors, immunoassays and small molecules.

Shares of this leading life sciences reagents and instruments company have considerably underperformed the broader market over the past year. TECH has declined 28.5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 16.1%. In 2025, TECH stock is down 26%, compared to the SPX’s 9.7% rise on a YTD basis. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.